Clinical trial

Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Active, not recruiting · Not applicable · 8 countries · Registry ID NCT06680674

Active, not recruitingNot applicableObservational

What this study is about

Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays. However, the pharmacological treatment of diabesity has made significant progress in recent years. The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include: 1. to determine the prevalence of causes and duration of hospitalization 2. to investigate the treatments used 3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed

SexAll

Healthy volunteersNot accepted

ConditionDiabetes Mellitus, Obesity

Full registry criteria

Inclusion Criteria: * Hospitalized at the time of the survey for any cause * Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria) * Age ≥ 18 years * Written informed consent Exclusion Criteria: * Patients in wards and units other than internal medicine wards (such as outpatient areas, emergency departments, skilled nursing and intensive care units, etc.) * Paediatric patients (Age \< 18 years) * Patients without a diabetes diagnosis

Treatments and study arms

Routine care for people with diabetes, with or without obesity, in the hospital setting

Other

Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.